[1]
S. Jović, R. Kozomara, S. Stošić, S. Jovandić, K. Zeljić, and G. Šupić, “Pathogenic TP53 mutations influence chemotherapy response and survival rate of patients with HPV-negative oral carcinomas”, Vojnosanit Pregl, vol. 79, no. 11, Dec. 2022, doi: 10.2298/VSP200525068J.